Article Versions Notes

Reverchon J, Tuloup V, Garreau R, Nave V, Cohen S, Reix P, Durupt S, Nove-Josserand R, Durieu I, Reynaud Q, et al. Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis. Pharmaceutics. 2022; 14(8):1750. https://doi.org/10.3390/pharmaceutics14081750

Reverchon, Jérémy, Vianney Tuloup, Romain Garreau, Viviane Nave, Sabine Cohen, Philippe Reix, Stéphane Durupt, Raphaele Nove-Josserand, Isabelle Durieu, Quitterie Reynaud, and et al. 2022. "Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis" Pharmaceutics 14, no. 8: 1750. https://doi.org/10.3390/pharmaceutics14081750

Reverchon, J., Tuloup, V., Garreau, R., Nave, V., Cohen, S., Reix, P., Durupt, S., Nove-Josserand, R., Durieu, I., Reynaud, Q., Bourguignon, L., Charles, S., & Goutelle, S. (2022). Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis. Pharmaceutics, 14(8), 1750. https://doi.org/10.3390/pharmaceutics14081750